Impact of Traditional Korean Medicine Use on Medical Costs in Patients with Cancer in Korea
Complementary Medicine Research · 23.03.2026 · 33 (3) · 211-224
DOI: 10.1159/000551613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Complementary Medicine Research, online erschienen am 23.03.2026. Verfasst von Ji-Eun Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Humanities and Social Medicine, School of TKM, Pusan National University, Yangsan, Republic of Korea. Hauptthemen laut MEDLINE: Neoplasms, Medicine, Korean Traditional, Complementary Therapies, Health Care Costs. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Introduction
Cancer remains a leading cause of death worldwide, and many patients use traditional medicine (TM) or complementary and alternative medicine (CAM) to manage symptoms; however, their economic impact remains unclear. In Korea, traditional Korean medicine (TKM) is practiced alongside Western medicine (WM); however, some CAM practices lie outside licensed TKM. This study investigated TKM use and its costs among cancer patients, examining its relationship with WM and CAM costs.
Methods
This study classified cancer patients from the 2016 Korean Health Panel Survey (KHPS) into treatment and comparison groups based on TKM use in 2017. Propensity score matching (PSM) was applied to ensure comparability, while WM and CAM costs in 2018 were analyzed using generalized linear models and marginal effects.
Results
After 1:2 PSM, 374 cancer patients were included (125 TKM users; 249 nonusers). TKM use was not significantly associated with WM costs; however, it was linked to reduced CAM costs. TKM costs showed no significant association with WM or CAM costs. Subgroup analysis revealed that TKM use was associated with a greater decrease in CAM costs among survivors diagnosed more than 5 years prior.
Conclusion
TKM use among cancer patients was associated with reduced CAM costs but not with WM costs. The CAM cost-saving effect was more substantial in long-term survivors, suggesting a shift toward institutionalized TKM use; however, increased TKM spending did not further reduce CAM costs. These findings imply a need for policies that promote evidence-based appropriate TKM use to improve healthcare cost efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Humanities and Social Medicine, School of TKM, Pusan National University, Yangsan, Republic of Korea.
- Haneum Neuropsychiatry Clinic of Korean Medicine, Seoul, Republic of Korea.
- College of TKM, Dongshin University, Naju city, Republic of Korea.
- College of TKM, Dongshin University, Naju city, Republic of Korea, dskim20@dsu.ac.kr.
Zitieren
APA
Yu, J. E., Kwak, H. Y., Ahn, E., & Kim, D. (2026). Impact of Traditional Korean Medicine Use on Medical Costs in Patients with Cancer in Korea. Complementary Medicine Research, 33(3), 211-224. https://doi.org/10.1159/000551613
Vancouver
Yu JE, Kwak HY, Ahn E, Kim D. Impact of Traditional Korean Medicine Use on Medical Costs in Patients with Cancer in Korea. Complementary Medicine Research. 2026;33(3):211-224. doi:10.1159/000551613
BibTeX
@article{Yu2026,
author = {Yu, Ji-Eun and Kwak, Hui-Yong and Ahn, Eunji and Kim, Dongsu},
title = {Impact of Traditional Korean Medicine Use on Medical Costs in Patients with Cancer in Korea},
journal = {Complementary Medicine Research},
year = {2026},
volume = {33},
number = {3},
pages = {211--224},
doi = {10.1159/000551613}
}
EUVIMED